Newest first. 5.2k questions across 107 tags.
Every summary I read says nausea is "the most common adverse event" and then quotes a single percentage, usually without saying which trial, which dose or which…
I have been reading the prescribing information for several agents in this class side by side and something bothers me. The ladders themselves are completely…
Conditions: CPC · GGPeps · Poland. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works; the question…
Conditions: SURMOUNT-OSA · injection-site erythema. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
Conditions: 98.8% · tirzepatide · WXT. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
For reference: MKM · Hubei Jianxiang Bioscience. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each…
I would like to know how much of this is established and how much is a reasonable story. I would rather understand the derivation than memorise the outcome. Two…
The specifics, since they change the answer: fibrillation · ecnoglutide · 37 °C. I would like the mechanism, because I want to be able to reason about the cases…
The particulars: 15 mg · survodutide. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to reason…
For reference: QYB · survodutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
I keep a written log of every draw with date, volume and syringe type. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer…
I have three data points across nine months, which I hope is enough to see a trend. I want to understand what this actually establishes, as opposed to what it is…
The specifics, since they change the answer: a wine cooler · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a…
For reference: SURMOUNT-OSA · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
Stated plainly: a 30G needle · cagrilintide · 10 mg/mL. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
What I am working with: 5 mg · cagrilintide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My background…
What I am working with: dulaglutide · 37 °C. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What…
What I am working with: 5 mg · 2.5 mL · bacteriostatic water. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
Numbers first: cagrilintide · 2–8 °C · twenty-eight days. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can…
What I have: 2 mg · dulaglutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
Numbers first: a GLP-1 receptor agonist · tirzepatide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
What I have: an HPLC purity test · orforglipron. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Details up front: FLOW · orforglipron. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
Numbers first: 2 mg · orforglipron. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…